Oncology
Sattva Neelapu, M.D.
Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dr. Sattva S. Neelapu is a physician-scientist and professor in the Department of Lymphoma and Myeloma at The University of Texas MD Anderson Cancer Center, specializing in hematologic oncology with a focus on B-cell malignancies. His clinical and translational research centers on developing novel immunotherapeutic strategies, particularly chimeric antigen receptor (CAR) T-cell therapies for lymphomas and myeloma. Dr. Neelapu led pivotal clinical trials of axicabtagene ciloleucel, a CD19-targeti
35+
Years in Practice
Credentials
Board Certifications
- American Board of Internal Medicine Medical Oncology
- 2005 Texas Medical License
Education & Training
- 1991 Jawaharlal Institute of Post-Graduate Medical Education and Research, Pondicherry, IN, Medicine, MBBS
- 2001-2004 Postdoctoral Fellowship, Tumor Immunology and Immunotherapy, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- 1998-2001 Clinical Fellowship, Medical Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- 1994-1995 Chief Resident, Internal Medicine, Coney Island Hospital, Brooklyn, New York
- 1993-1995 Clinical Residency, Internal Medicine, Coney Island Hospital, Brooklyn, New York
Peer Recognition
- American Association for the Advancement of Science — AAAS Fellow
2024
- American Society of Clinical Oncology — ASCO Career Development Award
2006-2009 (4 years)
- American Society of Hematology — ASH Scholar Award
2007-2009 (3 years)
- Doris Duke Charitable Foundation — Clinical Scientist Development Award
2008-2011 (4 years)
- Indo-American Cancer Association — Outstanding Achievement Award
2018
Recognition & Leadership
Awards & Honors
- 2025 Emil Frei, III Award of Excellence in Translational Research, The University of Texas MD Anderson Cancer Center
- 2025 Waun Ki Hong Award for Excellence in Team Science, The University of Texas MD Anderson Cancer Center
- 2024 Otis W. and Pearl L. Walters Faculty Achievement Award in Clinical Research, The University of Texas MD Anderson Cancer Center
- 2023 Mentor of the Year Award, Division of Cancer Medicine Fellowship Program, The University of Texas MD Anderson Cancer Center
- 2023 President's Recognition of Faculty Excellence in Research, The University of Texas MD Anderson Cancer Center
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- University of Texas MD Anderson Cancer Center
Languages
English
Experience
35+ years in practice